Nitromed CEO
Executive Summary
Nitromed CFO Kenneth Bate will succeed interim CEO Jerry Karabelas, the company announces Jan. 22. Bate joined Nitromed in March as part of a management shake-up to jump-start sales of the firm's heart failure therapy for African Americans, BiDil (1"The Pink Sheet" March 27, 2006, p. 14). Bate has held vice president positions at Millennium and Biogen Idec...
You may also be interested in...
NitroMed Aims To Revive BiDil With CEO Change, Managed Care Push
NitroMed's strategy for jump-starting sales of BiDil includes renewed efforts to get favorable formulary placement for the heart failure drug
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.